CD8A and melanoma: Altogether, our findings reveal that P-selectin binding and expression of integrin VLA-1 by circulating Melan-A specific CD8+ T cells correlate significantly with the survival of melanoma patients, suggesting an important role in antitumor immunity and the potential to use of these analytes as biomarkers.